Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection

Antiviral Therapy

Volumn 18, Issue 7, 2013, Pages 945-948

  Gracey, David M ^a,b   Snelling, Paul ^a   McKenzie, Paul ^a,b   Strasser, Simone I ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; TENOFOVIR DISOPROXIL;

ADULT; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LIVER BIOPSY; MALE; MIDDLE AGED; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

ADENINE; ADULT; ANTIVIRAL AGENTS; BIOPSY; CREATININE; FANCONI SYNDROME; HEPATITIS B, CHRONIC; HUMANS; KIDNEY; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; PHOSPHATES; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84890865046     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2649     Document Type: Article

References (18)

1. Gallant JE, De Jesus E, Arribas JR, et al. Tenofovir D F, emtricitabine, and efavirenz vs zidovudine, lamivudine and efavirenz for HIV. N Engl J Med 2006;354:251-260.
2. Yuen M F, Lai C. Treatment of chronic hepatits B: evolution over two decades. J Gastroenterol Hepatol 2011;26 Suppl 1:138-143.
3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662.
4. European Association For The Study Of The Liver. Clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242.
5. Liaw Y F, Leung N, Kao JH, et al. Asian-Paciic consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263-283.
6. Ratcliffe L, Beadsworth M, Pennell A, et al. Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients. AIDS 2011;25:1051-1056.
7. Daudé M, Rostaing L, Saune K, et al. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. Transplantation 2011;91:916-920.
8. Hall AM, Hendry BM, Nitsch D, et al. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 2011;57:773-780.
9. Fanconi G. [Infantile nephrotic glucosuric dwarism with hypophosphataemic rickets]. Jahrb Kinderheilkd 1936;147:299-338. German.
10. Fontana RJ. Side effects of long-term oral antiviral therapy for Hepatits B. Hepatology 2009;49 Suppl 1:S185-S195.
11. Gara N, Zhao X, Collins MT, et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther 2012;35:1317-1325.
12. Van Rompay K K A, Durand-Gasselin L, Brignolo LL, et al. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother 2008;52:3144-3160.
13. Pol S, Lampertico P. First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real life' settings: from clinical trials to clinical practice. J Viral Hepat 2012;19:377-386.
14. Mauss S, Berger F, Filmann N, et al. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol 2011;55:1235-1240.
15. Lampertico P, Soffredini R, Vigano M, et al. 2 Year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatits B: a multicentre European study in clinical practice. Hepatology 2011;54 Suppl 1:262A.
16. Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double blind, randomized, placebo controlled studies. Kidney Int 2004;66:1153-1158.
17. Gupta SK, Eustace JA, Winton JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005;40:1559.
18. Liaw YF, Leung N, Kao JH, et al. Asian-Paciic consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263-283.